TFF Pharmaceuticals, Inc.
DelistedCIK 1733413fmd_1JZ4ZW8YDHC1QS8M4ARTDK66EXManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Sep 30, 2024, 25 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Total revenues | – | – | 0 | 0 | 1 |
| Net interest income | 0 | 0 | 0 | 0 | – |
| Research and development | 9 | 11 | 21 | 18 | 12 |
| Total operating expenses | 12 | 19 | 32 | 32 | 23 |
| Operating income | (12) | (19) | (32) | (32) | (22) |
| Interest expense | – | – | – | – | 0 |
| Interest and investment income | – | – | – | 0 | 0 |
| Other non-operating income (expense) | 0 | 0 | 1 | 0 | 1 |
| Net income from continuing operations | – | – | 31 | 32 | – |
| Net income | (12) | (19) | (31) | (32) | (21) |
| Net income to common shareholders | (37) | (19) | – | – | – |